The largest database of trusted experimental protocols

4 protocols using anti sf3b1

1

Immunoblotting Analysis of SF3B1 in Transfected Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunoblotting of SF3B1/FLAG-SF3B1proteins in transiently-transfected HEK293T and stably-transduced TF1 and K562 cells in
which transcriptome analysis was done in parallel, Western blotting using a mouse
anti-human-SF3B1 antibody (Abcam #172634) at 1:1000 dilution was used.
Immunoblotting following affi nity purification of SF3B1 in HEK293T and TF1 cells was
performed as previously described, and primary antibodies were: anti-SF3B1 (Bethyl
Laboratories, A300–996A, 1:1,000), anti-ACTIN (Sigma, A2066, 1:2,000),
anti-DYKDDDDK (GenScript, A00187, 1:1,000), anti-SUGP1 (Bethyl
Laboratories A304–675A-M, 1:1,000), and anti-PHF5A (Proteintech 15554–1-AP,
1:1000)17 (link). Secondary antibodies
were: Donkey anti-Rabbit IgG (LI-COR, 926–68073, 1:5,000) and Goat anti-Mouse IgG
(LI-COR, 926–32210, 1:5,000).
+ Open protocol
+ Expand
2

Antibody-based Western Blotting and Immunoprecipitation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used for Western blotting or immunoprecipitation: anti-SF3B1 (Bethyl Laboratories, A300-996A-T, MBL International, D221-3), rabbit anti-cleaved Notch1 (Cell Signaling Technology, 4147S), rabbit anti–β-actin (Cell Signaling Technology, 4967S), rabbit anti-USP7 (Bethyl Laboratories, A300-033A), rabbit anti-GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (Cell Signaling Technology, 2118S), rabbit anti-CHEK2 (Bethyl Laboratories, A300-618A), mouse immunoglobulin G2b (IgG2b) (MBL International, M077-3), P5091 (Selleck Chemicals, S7132), PR619 (Sigma-Aldrich, SML0430), b-AP15 (Selleck Chemicals, S4920), ML323 (Sigma-Aldrich, SML1177), BML277 (MedChem Express, HY-13946), BML277 (Sigma-Aldrich, C3742, in vivo), SCH900776 (MedChem Express, HY-15532), camptothecin (Selleck Chemicals, S1288), flavopiridol (Sigma-Aldrich, F3055), topotecan (Sigma-Aldrich, T2705), etoposide (Sigma-Aldrich, E1383), mitoxantrone (European pharmacopoeia reference standard, M2305000), doxorubicin (Sigma-Aldrich, 44583), and E7107 and H3B-8800 (H3 Biomedicine).
+ Open protocol
+ Expand
3

Western Blot Antibody Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blotting was performed as described (Zhang et al. 2019a (link)) with the following primary antibodies: anti-SF3B1 (1:1000; Bethyl Laboratories A300-996A), anti-GST (1:1500; Invitrogen A5800), anti-SUGP1 (1:1000; Bethyl Laboratories A304-675A-M), anti-DDX46 (1:1000; Bethyl Laboratories A301-052A-T) used with Immuno Shot reagent 1 (Cosmo Bio), anti-HA rabbit (1:1000; Abm G166), anti-HA mouse (1:1000; Sigma-Aldrich H3663), and anti-ACTIN (1:2000; Sigma-Aldrich A2066).
+ Open protocol
+ Expand
4

Immunoblotting of Protein Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes (Bio-Rad), followed by immunoblotting with primary and secondary antibodies. Primary antibodies were: anti-SF3B1 (Bethyl Laboratories, A300–996A, 1:1,000), anti-ACTIN (Sigma, A2066, 1:2,000), anti-HA rabbit polyclonal (Abm, G166, 1:1,000), anti-HA mouse monoclonal (Sigma, H3663, 1:1,000), anti-DYKDDDDK (GenScript, A00187, 1:1,000), anti-SUGP1 (Bethyl Laboratories, A304–675A-M, 1:1,000), anti-RBM6 (ABclonal, A10391, 1:1,000), anti-U2AF2 (Sigma, U4758, 1;10,000), and anti-GST (Invitrogen, A5800, 1:1,500). Secondary antibodies were: Donkey anti-Rabbit IgG (LI-COR, 926–68073, 1:5,000), and Goat anti-Mouse IgG (LI-COR, 926–32210, 1:5,000). Immunofluorescence was detected using either the Odyssey Infrared Imager (LI-COR) or the ChemiDoc Imaging System (Bio-Rad).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!